Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

C3_RECTUM_ADENO_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C20.92& Cause of death: ICD-10 — C20.92& Cancer registry: Topography ICD-O-3 — C19\|C20 Cancer registry: Morphology ICD-O-3 — 8140 Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	3763
4. Check minimum number of events None	3763
5. Include endpoints None	3763
6. Filter based on genotype QC (FinnGen only)	3763

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_RECTUM_ADENO_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C2092
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2092
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C19\|C20
CANC_TOPO_EXCL
CANC_MORPH	8140
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Adenocarcinoma and papilloma adenocarcinoma of rectum

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3763	1412	2351
Unadjusted period prevalence (%)	0.83	0.48	1.04
Median age at first event (years)	67.77	66.17	68.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3305: Matched controls
33046

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D75

ICPC

Malignant neoplasm colon/rectum

815.1

323.0

364

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

323.0

487

A03FA01

ATC

metoclopramide; systemic, rectal

17.8

323.0

1671

1795

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

5.4

323.0

1568

4747

JG1CG

NOMESCO Finland

Extensive MRI of rectum

805.2

323.0

423

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

323.0

702

TJF80

NOMESCO Finland

Ostomy education

185.7

323.0

436

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

323.0

347

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

323.0

411

WZC30

NOMESCO Finland

Teaching

7.8

323.0

899

1507

JN4BD

NOMESCO Finland

Extensive body CT

24.3

323.0

1194

751

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

323.0

423

H02AB02

ATC

dexamethasone; systemic

99.5

323.0

912

126

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

323.0

1531

XX3DW

NOMESCO Finland

Time consuming IT work

13.9

323.0

750

685

Z93.3

ICD-10 Finland

Colostomy status

238.2

323.0

435

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

283.3

323.0

622

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

125.5

323.0

398

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

27.1

323.0

1615

1124

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

323.0

469

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

498.0

323.0

358

JN4AD

NOMESCO Finland

Body CT examination

17.7

323.0

710

503

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1134.8

323.0

400

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

323.0

770

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

3663.9

323.0

341

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

514

JG1BG

NOMESCO Finland

MRI of rectum

1585.4

323.0

533

JFF23

NOMESCO Finland

Transversostomy

339.1

323.0

697

B01AB05

ATC

enoxaparin; parenteral

5.7

323.0

1809

5744

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

600.9

323.0

422

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

323.0

575

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

352

A04AA02

ATC

granisetron; systemic, transdermal

1528.3

323.0

810

WX302

NOMESCO Finland

Thoracal epidural anesthesy

62.1

323.0

1066

251

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3242.3

323.0

566

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

23.1

323.0

521

265

WX408

NOMESCO Finland

General anesthesy, balanced

4.9

323.0

1463

4616

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

406.7

323.0

398

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1019.8

323.0

364

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

323.0

428

L01BC06

ATC

capecitabine; oral

+∞

323.0

1472

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

35.9

323.0

564

188

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

323.0

2882

UJF32

NOMESCO Finland

Coloscopy

12.5

323.0

2294

5080

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

323.0

2785

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

1790

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

20.2

323.0

889

591

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

323.0

387

UJG02

NOMESCO Finland

Proctoscopy

25.8

306.3

437

194

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

1033.1

294.2

284

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

231.1

289.2

295

C61

ICD-10 Finland

Malignant neoplasm of prostate

283.2

282.6

285

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

279.1

264

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2592.5

262.8

251

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2546.4

258.5

247

ZX090

NOMESCO Finland

Other technic of radiotherapy

650.0

247.5

242

WX600

NOMESCO Finland

Single shot through catheter

75.7

239.4

272

WF002

NOMESCO Finland

Radical radiotherapy

156.8

235.2

247

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2294.7

235.0

225

A04AA01

ATC

ondansetron; systemic, rectal

18.7

230.0

364

217

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

229.9

218

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

229.7

229.9

235

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

151.4

226.8

239

JN4CD

NOMESCO Finland

Very extensive body CT

19.6

226.1

352

200

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

1147.4

222.4

215

WF049

NOMESCO Finland

Radiotherapy of metastasis

2147.7

221.2

212

Z51.5

ICD-10 Finland

Palliative care

14.0

215.3

384

308

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

212.8

202

TPH07

NOMESCO Finland

Cathetrisation of artery

5.2

205.7

722

1681

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

1028.2

200.1

194

WX402

NOMESCO Finland

General anaesthesia

4.7

198.3

771

1996

N02AA05

ATC

oxycodone; systemic

4.7

198.0

775

2020

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

515.1

197.7

195

ZXE20

NOMESCO Finland

More than three and less than five hours

4.4

197.3

833

2341

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

676.9

196.2

192

ZXC96

NOMESCO Finland

Robot assisted procedure

50.9

195.7

237

B01AB10

ATC

tinzaparin; parenteral

8.5

186.2

435

581

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

177.7

169

JFF10

NOMESCO Finland

Loop enterostomy

125.9

177.2

190

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

453.3

174.5

173

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

226.5

167.8

172

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

159.6

152

WF003

NOMESCO Finland

Adjuvant radiotherapy

411.6

158.7

158

SPAT1125

SPAT

Stoma care and guidance

18.6

158.3

250

145

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9.4

153.8

335

393

116

Kela drug reimbursment

Prostate cancer

+∞

150.1

143

WF004

NOMESCO Finland

Palliative radiotherapy

745.0

146.2

143

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

7.3

142.0

364

552

A04AA55

ATC

palonosetron, combinations; systemic

+∞

139.5

133

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

101.0

132.2

145

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

6.0

128.0

380

700

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

127.9

122

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.5

126.9

246

230

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.0

123.6

559

1605

Z93

ICD-10 Finland

Artificial opening status

167.6

123.2

129

A04AD12

ATC

aprepitant; systemic

1210.8

120.6

117

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

56.1

117.7

140

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

+∞

117.4

112

ZX120

NOMESCO Finland

Intravenous

4.5

115.3

448

1110

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

11.0

110.3

218

211

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.1

107.9

369

797

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

106.8

102

JN3AD

NOMESCO Finland

Abdominal CT examination

4.4

105.5

420

1061

115

Kela drug reimbursment

Breast cancer

+∞

104.7

100

SPAT1262

SPAT

Handing over of treatment supplies

2.6

102.1

895

4064

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

11.3

99.9

194

181

Z51.0

ICD-10 Finland

Radiotherapy session

997.2

99.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.5

96.4

502

1598

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

96.3

TQW40

NOMESCO Finland

Remowal of suture of skin

4.4

94.8

376

942

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.4

93.4

298

592

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.8

93.2

338

773

JF2AB

NOMESCO Finland

Colongraphy with X-ray

95.6

92.5

102

JGB36

NOMESCO Finland

Wide excision of rectum

+∞

92.1

369

Kela drug reimbursment

Regorafenib

+∞

92.1

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

92.1

N02BE01

ATC

paracetamol; systemic, rectal

2.6

91.8

2839

23154

L01BC59

ATC

trifluridine, combinations; systemic

+∞

91.0

A79

ICPC

Malignancy NOS

141.1

90.5

PJA12

NOMESCO Finland

Sentinel node biopsy

902.0

90.2

D18

ICPC

Change in faeces/bowel movements

8.9

89.9

199

236

Z43.3

ICD-10 Finland

Attention to colostomy

139.6

89.5

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

891.4

89.1

WW500

NOMESCO Finland

Blood transfusion

8.5

88.6

202

252

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

20.5

88.5

134

WX306

NOMESCO Finland

Lumbar epidural anesthesy

5.8

88.0

263

482

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

87.9

L03AA13

ATC

pegfilgrastim; parenteral

+∞

87.9

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

40.6

87.2

110

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

86.8

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

859.8

86.0

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

85.8

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

84.8

830

3942

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

223.1

84.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

84.7

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

15.1

83.7

142

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

81.6

R4110

NOMESCO Finland

Physiotherapy

2.3

80.9

971

5091

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

15.6

80.7

135

176

Kela drug reimbursment

Regorafenib

+∞

78.4

JAH00

NOMESCO Finland

Laparotomy

7.2

77.9

197

288

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.6

77.8

288

669

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

76.3

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

38.4

76.1

L02AE02

ATC

leuprorelin; implant, parenteral

39.5

75.8

D99

ICPC

Disease digestive system other

14.9

75.2

128

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

6.2

75.1

213

364

L03AA02

ATC

filgrastim; parenteral

71.6

73.6

1XC07

NOMESCO Finland

+∞

73.2

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

71.9

1257

7676

JJB10

NOMESCO Finland

Atypcal resection of liver

713.0

71.4

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

39.7

70.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

69.0

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

681.7

68.2

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

95.9

68.1

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

67.9

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

66.9

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

57.0

66.0

JFB00

NOMESCO Finland

Partial resection of small intestine

11.0

65.4

128

121

Z43.2

ICD-10 Finland

Attention to ileostomy

103.6

65.1

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.0

64.9

187

326

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

29.1

64.8

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

323.0

63.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.0

63.1

271

723

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

43.7

62.2

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

99.1

62.1

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

+∞

61.6

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

318.6

61.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

608.8

60.9

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

60.6

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

8.7

59.8

133

159

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

157.8

59.1

Y77

ICPC

Malignant neoplasm prostate

128.3

59.0

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.5

58.5

221

521

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

58.5

E0000UV

ATC

1.9

57.4

1218

7820

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.2

56.8

159

267

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

286.1

55.4

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

18.9

55.0

K56.7

ICD-10 Finland

Ileus, unspecified

7.5

54.4

132

181

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

53.3

B01AB04

ATC

dalteparin; parenteral

3.8

52.4

240

675

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

52.4

434

1834

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

+∞

52.2

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

7.3

51.7

128

181

XX1AD

NOMESCO Finland

Other CT-examination

264.5

51.2

JFF24

NOMESCO Finland

Laparoscopic transversostomy

+∞

51.2

L02BB03

ATC

bicalutamide; oral

505.2

50.5

Z93.2

ICD-10 Finland

Ileostomy status

33.6

50.5

L01XE21

ATC

[U] regorafenib; oral

+∞

50.1

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

50.1

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

12.4

49.8

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

494.9

49.5

L02BG04

ATC

letrozole; oral

39.5

49.2

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

28.0

48.3

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

48.0

R4190

NOMESCO Finland

Nutritional therapy

6.6

47.0

125

196

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

47.0

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

47.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

46.9

572

2918

ZZR00

NOMESCO Finland

Flap of skin

13.8

46.5

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

47.4

46.1

WX704

NOMESCO Finland

Intubation

3.1

46.0

273

934

S18

ICPC

Laceration/cut

1.7

45.3

1342

9390

N03AX16

ATC

pregabalin; oral

1.9

45.0

775

4535

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

44.9

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

36.2

44.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.7

42.8

197

555

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

42.8

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

26.1

42.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.9

42.4

144

304

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

217.6

42.0

HAC20

NOMESCO Finland

Total mastectomy

114.0

41.8

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.1

41.1

116

197

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.7

40.9

186

519

JFF26

NOMESCO Finland

Sigmoidostomy

54.0

40.5

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.1

40.2

165

421

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.6

39.7

119

218

6435

FHL

Abdominoperineal resection and colostomy

391.8

39.1

V03AF03

ATC

calcium folinate; systemic

391.8

39.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

39.0

1416

10354

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

29.3

38.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

38.4

810

5040

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

37.6

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

15.4

37.4

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.0

37.2

234

831

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

25.1

37.1

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

371.3

37.1

JJB30

NOMESCO Finland

Excision of two segments of liver

371.3

37.1

JAH01

NOMESCO Finland

Laparoscopy

4.2

36.9

145

355

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.7

36.9

115

6434

FHL

Anterior resection

45.5

36.9

L02BA01

ATC

tamoxifen; oral

131.4

36.8

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

25.9

36.7

L01BC53

ATC

tegafur, combinations; systemic

+∞

36.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

36.5

Z3231

NOMESCO Finland

Registered nurse

1.7

36.3

865

5579

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

98.6

35.8

K92.1

ICD-10 Finland

Melaena

2.8

35.5

239

886

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

35.5

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

35.5

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

35.2

330

1473

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

34.8

1179

8381

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

37.1

34.7

Z31.5

ICD-10 Finland

Genetic counselling

4.7

34.3

119

258

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

65.7

34.0

KCC10

NOMESCO Finland

Cystoprostatectomy

340.4

34.0

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

176.7

33.8

ZXD05

NOMESCO Finland

Urgent procedure

1.7

33.6

970

6585

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

23.2

33.5

SPAT1153

SPAT

Removal of sutures

1.7

33.5

997

6828

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.7

33.4

150

414

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

+∞

33.4

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.1

33.1

108

219

A06AH03

ATC

naloxegol; oral

15.7

33.0

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

330.2

32.9

JFB30

NOMESCO Finland

Right hemicolectomy

12.2

32.9

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

91.0

32.8

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.2

32.6

128

314

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

32.3

NK6AN

NOMESCO Finland

Total body bone isotope imaging

20.3

32.2

D70.82

ICD-10 Finland

Drug-induced neutropenia

16.7

31.9

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

319.9

31.9

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

319.9

31.9

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.8

31.8

139

376

HAB40

NOMESCO Finland

Wedge excision of mammary gland

19.5

31.7

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

31.3

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

31.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

31.2

264

1116

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

15.7

31.2

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

85.9

30.8

D77

ICPC

Malignant digestive neopl other/NOS

161.4

30.7

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

161.4

30.7

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.1

30.6

109

WX110

NOMESCO Finland

Local anesthesy

1.5

30.6

1862

15099

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

8.5

30.4

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

30.2

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

30.2

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

14.4

30.1

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

304.9

29.8

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

304.9

29.8

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.2

29.8

184

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

156.3

29.7

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

25.9

29.7

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

34.9

29.6

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.7

29.5

R50.9

ICD-10 Finland

Fever, unspecified

2.0

29.4

416

2226

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

29.2

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

29.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

29.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

29.2

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

29.2

C209

ICD-10 Finland

+∞

29.2

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

8.9

28.9

C50.99

ICD-10 Finland

Breast, unspecified

294.3

28.8

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

151.2

28.7

LEC00

NOMESCO Finland

Partial excision of vagina

151.2

28.7

J01MA12

ATC

levofloxacin; systemic

1.8

28.4

601

3694

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

28.2

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

28.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

28.1

557

3353

D16

ICPC

Rectal bleeding

4.4

28.0

105

247

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

283.7

27.8

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.0

27.8

171

599

A02BC02

ATC

pantoprazole; systemic

1.5

27.4

1933

16011

P01AB01

ATC

metronidazole; oral, rectal

1.6

27.2

1062

7705

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

27.1

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

11.2

27.0

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

20.2

26.9

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

273.1

26.7

HA1AA

NOMESCO Finland

X-ray mammography

4.3

26.3

100

239

TJG20

NOMESCO Finland

Transanal irrigation

26.0

26.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

26.1

ZXE00

NOMESCO Finland

One hour or less

1.5

25.9

1120

8297

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.0

25.8

122

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

25.8

229

992

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

262.5

25.7

TPX15

NOMESCO Finland

Removal of vascular injection port

20.2

25.6

A06AD11

ATC

lactulose; oral

1.8

25.6

507

3044

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

11.3

25.6

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

9.6

25.4

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

28.6

25.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

25.3

256

1184

G04BE03

ATC

sildenafil; oral

10.6

25.2

JEA00

NOMESCO Finland

Appendectomy

2.7

25.2

183

711

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

25.0

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

25.0

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

+∞

25.0

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.5

25.0

121

357

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.9

24.7

104

273

UKC02

NOMESCO Finland

Cystoscopy

1.7

24.6

527

3240

JFF30

NOMESCO Finland

Other colostomy

56.4

24.0

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

37.8

23.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

23.8

196

816

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.6

23.6

111

320

WX725

NOMESCO Finland

Noninvasive ventilation

2.8

23.5

160

598

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

23.1

175

694

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

+∞

22.9

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

22.9

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

22.9

C50

ICD-10 Finland

Malignant neoplasm of breast

+∞

22.9

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

22.9

L02BX02

ATC

degarelix; parenteral

+∞

22.9

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

22.9

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.5

22.8

186

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

30.2

22.8

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

22.7

139

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

22.6

356

1972

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.2

22.5

207

R33

ICD-10 Finland

Retention of urine

2.0

22.2

312

1654

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

35.3

22.0

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

21.9

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

21.9

GDC00

NOMESCO Finland

Lobectomy of lung

62.9

21.8

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

115.7

21.6

J01MA02

ATC

ciprofloxacin; systemic

1.5

21.4

1169

9007

JFB20

NOMESCO Finland

Ileocaecal resection

14.0

21.3

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

11.6

21.2

Z71.8

ICD-10 Finland

Other specified counselling

1.6

21.1

606

4030

ZX050

NOMESCO Finland

Stereotactic radiotherapy

34.0

21.1

G04CA02

ATC

tamsulosin; oral

1.5

21.0

917

6737

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

60.4

20.9

JFB46

NOMESCO Finland

Resection of sigmoid colon

6.7

20.9

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

+∞

20.8

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

20.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

20.8

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

20.8

ZX121

NOMESCO Finland

Central venous catheter

21.6

20.8

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.4

20.8

176

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

20.7

244

1204

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.0

20.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.5

20.6

112

JHA00

NOMESCO Finland

Anal or perianal incision

5.6

20.6

108

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

110.7

20.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

8.9

20.3

UJF34

NOMESCO Finland

Left colonoscopy

8.0

19.9

D29

ICPC

Digestive symptom/complaint other

4.1

19.8

189

1XC08

NOMESCO Finland

+∞

19.8

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

19.8

X76

ICPC

Malignant neoplasm breast female

+∞

19.8

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

19.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

19.8

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

105.6

19.6

NET99

NOMESCO Finland

Other operation on pelvis

201.0

19.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

201.0

19.6

D28

ICPC

Limited function/disability (D)

12.2

19.5

KC1GB

NOMESCO Finland

Cystography with X-ray

24.7

19.5

D17

ICPC

Incontinence of bowel

6.7

19.3

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.7

19.0

227

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.9

18.8

125

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

18.8

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

190.9

18.5

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

38.6

18.5

JFB43

NOMESCO Finland

Left hemicolectomy

12.9

18.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

18.3

242

1252

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

16.2

18.3

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.8

18.2

130

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

19.4

18.2

R03AC02

ATC

salbutamol; inhalant

0.7

18.1

920

11697

R19.4

ICD-10 Finland

Change in bowel habit

3.3

18.0

291

WX882

NOMESCO Finland

High dependency care

3.0

17.8

104

355

WX002

NOMESCO Finland

Sedation and analgesia

1.6

17.7

577

3944

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

17.7

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

17.7

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

17.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

66.9

17.7

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

17.6

226

GDB10

NOMESCO Finland

Wedge resection of lung

36.9

17.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.9

17.5

118

S77

ICPC

Malignant neoplasm of skin

28.9

17.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

17.1

438

2813

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.9

17.0

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

50.2

17.0

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

16.9

165

749

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

63.6

16.7

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

16.7

509

7105

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

16.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

16.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

16.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

16.7

472

3112

JKA20

NOMESCO Finland

Cholecystectomy

2.7

16.6

116

443

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

170.7

16.5

ZX112

NOMESCO Finland

Subcutaneous

6.1

16.3

K61.1

ICD-10 Finland

Rectal abscess

12.2

16.3

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.9

16.3

A28

ICPC

Limited function/disability NOS

1.6

16.2

502

3387

JAD10

NOMESCO Finland

Repair of incisional hernia

5.8

16.1

XKD00

NOMESCO Finland

Uroflowmetry

1.6

16.1

517

3514

N02AX02

ATC

tramadol; systemic, rectal

1.4

16.1

1217

9817

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

16.0

456

6459

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

11.7

16.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

16.0

417

2689

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

21.0

16.0

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

60.3

15.8

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

33.5

15.7

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

15.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

15.6

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

15.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

15.6

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

15.6

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

15.6

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

+∞

15.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

15.6

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

15.6

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

26.4

15.6

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

85.4

15.6

LCD00

NOMESCO Finland

Hysterectomy

2.7

15.5

104

386

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

22.1

15.5

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.9

15.5

168

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

28.7

15.2

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

6.0

15.1

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

5.8

15.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

15.0

872

6695

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

15.0

222

1201

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

14.7

391

2533

K62.7

ICD-10 Finland

Radiation proctitis

+∞

14.6

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

14.6

125

533

KBV00

NOMESCO Finland

Insertion of stent into ureter

8.1

14.5

128

Kela drug reimbursment

Cancers of female genital organs

150.6

14.5

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

22.3

14.2

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.9

14.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

14.1

110

447

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

14.1

255

1476

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

17.6

13.8

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.5

13.8

181

ZZR10

NOMESCO Finland

Flap of skin and muscle

11.4

13.8

UJH02

NOMESCO Finland

Anoscopy

2.3

13.7

123

540

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

75.4

13.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

13.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

13.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

13.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.5

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

13.5

L01BC04

ATC

carmofur; oral

+∞

13.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

13.5

K56.0

ICD-10 Finland

Paralytic ileus

4.2

13.5

124

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

10.9

13.5

R11

ICD-10 Finland

Nausea and vomiting

1.9

13.5

202

1099

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

10.1

13.4

WGA11

NOMESCO Finland

Planning of pain management

18.3

13.3

JFA42

NOMESCO Finland

Endoscopic injection in colon

9.7

13.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

13.0

217

SPAT1131

SPAT

Colonoscopy

2.4

13.0

106

441

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

9.3

12.9

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

9.3

12.9

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

12.9

431

5955

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

50.2

12.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

12.7

116

511

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.8

12.7

142

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.4

12.7

A07DA03

ATC

loperamide; oral

2.3

12.6

118

527

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

12.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

12.5

L01EX05

ATC

regorafenib; oral

+∞

12.5

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

12.5

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

+∞

12.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

12.5

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

12.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

12.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

12.5

GDB20

NOMESCO Finland

Segmental resection of lung

+∞

12.5

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

12.5

JF2CG

NOMESCO Finland

Extensive MRI of colon

+∞

12.5

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

12.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

12.5

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

+∞

12.5

WX892

NOMESCO Finland

Monitored bed care

1.8

12.5

234

1373

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

6.0

12.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

12.3

518

6882

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

12.2

116

523

L02BG03

ATC

anastrozole; oral

37.7

12.2

JFB50

NOMESCO Finland

Other resection of colon

15.9

12.1

KBH20

NOMESCO Finland

Replantation of ureter

15.9

12.1

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

18.1

12.0

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

10.1

12.0

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.5

11.9

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

11.8

259

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

11.8

144

725

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

11.8

186

1028

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.2

11.8

113

513

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.1

11.7

112

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.5

11.7

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.1

11.7

108

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

16.4

11.6

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

19.0

11.6

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

22.9

11.6

K65.0

ICD-10 Finland

Acute peritonitis

4.0

11.5

114

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

11.5

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

11.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

11.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

11.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

11.5

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

11.5

1540A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]

+∞

11.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

11.5

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

11.5

JAG00

NOMESCO Finland

Repair of other hernia

13.6

11.4

Z93.8

ICD-10 Finland

Other artificial opening status

120.4

11.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

120.4

11.4

L02AE04

ATC

triptorelin; parenteral

120.4

11.4

SPAT1109

SPAT

Analgesia with portable analgesic pump

7.9

11.3

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

11.2

194

1107

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

9.6

11.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

11.2

444

3147

R01AD09

ATC

mometasone; nasal

0.7

11.1

696

8735

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

25.1

11.1

JJA20

NOMESCO Finland

Open biopsy of liver

12.7

11.1

G47.3

ICD-10 Finland

Sleep apnoea

0.7

10.9

325

4600

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

43.4

10.9

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

15.5

10.8

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.2

10.8

Z3226

NOMESCO Finland

Physiotherapist

1.4

10.7

479

3478

KA3EB

NOMESCO Finland

Antegrade pyelography

9.6

10.7

KA1FN

NOMESCO Finland

Isotope renography

7.2

10.7

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

17.8

10.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

10.6

165

909

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

10.6

290

1886

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.8

10.5

UJF32

SPAT

3.1

10.5

178

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

10.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

10.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

10.4

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

10.4

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

10.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

10.4

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

10.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

10.4

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

10.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

10.4

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

10.4

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

10.4

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

10.4

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

10.4

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

10.4

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

32.6

10.3

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

0.5

10.2

1603

ZXC40

NOMESCO Finland

Use of ultrasound

7.5

10.2

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.7

10.1

471

6185

M25.5

ICD-10 Finland

Pain in joint

0.7

10.0

393

5310

JAL30

NOMESCO Finland

Omentectomy

11.3

10.0

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

10.0

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

14.6

10.0

ZX100

NOMESCO Finland

Oral

3.6

10.0

120

Z93.4

ICD-10 Finland

Other artificial openings of gastrointestinal tract status

40.2

10.0

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

40.2

10.0

R18

ICD-10 Finland

Ascites

3.4

9.9

141

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

9.9

102

480

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.4

9.8

137

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

20.1

9.8

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.7

9.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

9.8

192

1144

N32.1

ICD-10 Finland

Vesicointestinal fistula

8.7

9.8

JFA70

NOMESCO Finland

Suture of small intestine

9.5

9.7

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.6

9.7

122

2085

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

9.7

376

5087

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.0

9.7

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.4

9.7

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

9.6

504

6512

XF612

NOMESCO Finland

Measurement of central venous pressure

11.4

9.5

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

8.4

9.5

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

6.3

9.5

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

100.3

9.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

100.3

9.4

R84

ICPC

Malignant neoplasm bronchus/lung

100.3

9.4

WGA10

NOMESCO Finland

Measurement of pain intensity

100.3

9.4

Z2446

NOMESCO Finland

Social worker

1.9

9.4

138

749

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.3

9.4

137

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

17.6

9.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

9.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

9.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

9.4

JFA68

NOMESCO Finland

Endoscopic insertion of prosthetic tube into colon

+∞

9.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

9.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

9.4

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

+∞

9.4

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

9.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

9.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

9.4

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

9.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

9.4

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.4

J01DB01

ATC

cefalexin; oral

1.3

9.3

2268

20876

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.0

9.3

N05AX08

ATC

risperidone; systemic

0.5

9.3

1584

R15

ICD-10 Finland

Faecal incontinence

2.4

9.3

309

JFF13

NOMESCO Finland

Terminal enterostomy

8.7

9.3

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

9.2

213

1328

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

9.2

113

573

R03DC03

ATC

montelukast; oral

0.6

9.2

156

2479

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

5.7

9.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

9.1

537

6821

WX610

NOMESCO Finland

Patient controlled analgesia

8.3

9.0

M01AH05

ATC

etoricoxib; oral

0.8

9.0

1152

13309

D07AA02

ATC

hydrocortisone; topical

1.5

9.0

300

2051

JHA10

NOMESCO Finland

Biopsy of anal canal

18.6

8.9

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

18.6

8.9

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

7.4

8.9

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.6

8.9

106

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.1

8.9

456

C01DA14

ATC

isosorbide mononitrate; oral

0.7

8.9

350

4728

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

8.8

460

R52.0

ICD-10 Finland

Acute pain

2.4

8.7

282

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

1950

8805

3.52

313.14

2.9

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1610

6308

3.71

307.65

3.3

2.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2506

12412

4.05

307.65

11.2

3.9

g/l

33.0

35.3

69.88

2433

11295

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1043

2883

4.62

307.65

2.6

2.3

umol/l

8.0

8.3

0.17

972

2484

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2563

12395

4.35

307.65

5.8

3.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2895

1648

72.80

307.65

10.0

1.4

ug/l

33.9

3.7

2.45

2652

1233

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

828

577

18.11

307.65

6.2

1.8

u/ml

647.0

110.4

0.63

765

465

(3022145) Colonoscopy Study observation

1572

2877

8.66

307.65

1.6

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1955

8193

3.88

307.65

3.5

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1028

2207

6.03

307.65

2.4

2.0

g/l

0.2

3.74

1001

1981

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

438

342

14.36

307.65

5.3

1.8

u/ml

57.0

443.5

0.66

392

310

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2754

14155

4.52

307.65

14.9

3.8

umol/l

11.2

12.4

4.97

2696

13217

(4035726)

816

825

12.35

307.65

1.3

1.2

—

(3032080) INR in Blood by Coagulation assay

2387

12898

3.32

272.28

8.6

11.2

inr

1.2

1.4

18.03

634

3538

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

848

2390

4.29

270.84

2.2

u/l

31.2

57.4

0.70

799

2007

(3002256) Pathology report gross observation

790

2143

4.40

265.09

1.3

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1057

3877

3.40

224.92

9.8

6.3

mmol/l

105.0

104.3

6.93

1045

3778

(3033658) Prothrombin time (PT) actual/Normal

1501

6839

2.99

218.83

5.1

3.6

90.2

84.4

16.35

1493

6656

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1805

9157

2.87

214.24

2.6

2.3

u/l

57.1

59.8

1.27

1738

8378

(3023368) Bacteria identified in Blood by Culture

1654

8334

2.76

194.11

5.3

3.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2479

15371

2.79

190.89

17.0

6.1

e9/l

3.9

4.4

21.71

2260

13113

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3051

22069

3.02

157.75

16.3

5.4

u/l

90.2

76.5

24.53

2971

20341

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1555

8464

2.43

144.72

4.4

2.6

u/l

32.2

36.2

1.05

1517

7930

(3037121) Protein [Mass/volume] in Urine

392

992

4.29

140.07

6.6

2.6

g/l

0.2

0.3

4.04

305

351

(3012095) Magnesium [Moles/volume] in Serum or Plasma

927

4364

2.49

114.37

5.8

2.5

mmol/l

0.8

16.43

886

3973

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1070

5383

2.38

113.82

9.8

2.2

mmol/l

2.5

2.4

16.62

1000

4588

(3015377) Calcium [Moles/volume] in Serum or Plasma

1566

9300

2.17

110.74

8.3

2.1

mmol/l

2.3

1.37

1433

7655

(3003694) ABO and Rh group [Type] in Blood

1241

6716

2.26

110.66

1.4

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2475

17834

2.13

101.51

6.0

4.4

mmol/l

7.0

6.9

1.24

2396

16660

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

346

1013

3.66

99.85

2.7

3.1

u/ml

0.3

1.51

191

591

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

453

1595

3.09

97.09

9.0

9.6

—

(40758558) Short blood count panel - Blood

1167

6483

2.16

94.80

13.4

4.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1998

13551

2.01

93.57

7.3

5.3

mmol/l

1.2

13.63

1848

11954

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

513

1994

2.82

91.70

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1457

8954

2.02

89.01

3.8

3.1

e6/l

109.4

75.9

0.41

1206

6820

(3002173) Hemoglobin [Mass/volume] in Arterial blood

658

2979

2.46

85.94

8.2

7.4

g/l

117.8

122.4

7.71

637

2862

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2120

14962

1.95

85.33

8.4

5.7

mmol/l

1.2

16.51

1793

12555

(36304419) Bacteria [Presence] in Urine

1294

7831

1.99

80.79

3.6

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1337

8205

1.98

80.01

3.7

3.0

e6/l

0.6

0.5

0.76

1088

6117

(3031040) Bacteria [#/volume] in Urine by Automated count

2518

19085

1.96

79.18

5.1

4.4

e6/l

2275.0

2119.7

0.03

316

(3003396) Base excess in Arterial blood by calculation

737

3641

2.27

78.20

7.7

6.7

mmol/l

1.0

1.2

0.93

619

2788

(3016502) Oxygen saturation in Arterial blood

690

3320

2.32

77.92

7.9

6.9

96.9

95.0

13.31

665

3182

(3027801) Oxygen [Partial pressure] in Arterial blood

737

3668

2.25

76.68

7.7

6.7

kpa

14.3

11.5

29.17

708

3484

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

737

3669

2.25

76.62

7.7

6.7

kpa

5.2

5.0

5.29

709

3489

(3014111) Lactate [Moles/volume] in Serum or Plasma

594

2711

2.41

75.50

6.0

6.3

mmol/l

1.3

1.4

1.37

571

2603

(3042936) Bacteria identified in Isolate by Culture

779

4128

2.12

68.40

2.3

2.0

—

(3018095) Leukocytes [#/volume] in Urine

1544

10336

1.84

67.88

4.4

3.5

e6/l

175.7

109.5

1.72

1247

7336

(3026782) Osmolality of Urine

987

5732

1.98

67.15

3.2

2.7

mosm/kgh2o

527.4

555.3

4.39

884

4783

(3000850) Epithelial cells [#/volume] in Urine

1042

6224

1.93

64.91

2.9

2.5

e6/l

5.0

4.5

0.41

929

5369

(3014007) Fractional oxyhemoglobin in Arterial blood

435

1938

2.41

57.48

8.4

8.6

95.2

93.4

9.67

435

1930

(3026008) Bacteria identified in Urine by Culture

1319

8760

1.78

56.97

3.6

3.2

—

(3000991) Gas panel - Venous blood

513

2511

2.21

54.16

7.1

7.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

799

4667

1.90

51.60

3.6

2.8

e6/l

2.6

2.0

0.71

480

2573

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

725

4158

1.92

49.25

2.3

2.7

20.1

22.6

4.90

631

3478

(3004789) Transferrin [Mass/volume] in Serum or Plasma

752

4465

1.85

45.49

2.3

2.6

g/l

2.3

2.22

708

4093

(3020779) Urea [Moles/volume] in Serum or Plasma

527

2805

2.02

44.08

5.2

6.8

mmol/l

9.7

11.2

4.04

502

2646

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

230

855

2.80

43.80

1.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

793

4837

1.81

43.75

2.3

2.6

umol/l

11.4

12.8

5.46

746

4423

(3025941) Bacteria identified in Stool by Culture

314

1371

2.41

42.99

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

295

1262

2.45

42.23

1.9

1.8

ug/l

2.4

1.6

0.64

264

1080

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

343

1574

2.30

41.87

8.7

mmol/l

24.1

24.4

1.04

329

1432

(3018572) Chloride [Moles/volume] in Blood

194

680

2.95

41.15

8.7

6.8

mmol/l

106.4

105.0

4.71

175

605

(3039000) Anion gap in Blood

194

680

2.95

41.15

8.7

6.7

mmol/l

11.0

11.3

0.81

175

605

(42870588) Differential panel, method unspecified - Blood

1328

9454

1.62

40.91

4.1

5.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2450

20165

1.62

40.79

5.7

4.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3237

28754

1.90

40.01

29.4

14.1

mg/l

37.3

25.0

60.00

3022

22662

(3018418) pH of Serum or Plasma

1223

8600

1.62

39.23

5.2

3.3

7.4

0.01

263

1502

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

809

5108

1.74

39.11

3.3

2.6

e6/l

1.0

1.2

0.42

484

2991

(3047181) Lactate [Moles/volume] in Blood

241

977

2.57

38.62

7.7

5.9

mmol/l

1.4

1.3

0.11

212

859

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

544

3061

1.91

38.35

5.0

3.3

—

(3006504) Eosinophils/100 leukocytes in Blood

1683

12875

1.55

37.02

4.4

5.6

2.7

3.0

6.38

1562

11781

(3019069) Monocytes/100 leukocytes in Blood

1689

12934

1.55

36.96

4.6

5.9

9.1

8.9

0.99

1569

11878

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

800

5106

1.72

36.94

1.8

—

(3022096) Basophils/100 leukocytes in Blood

1645

12532

1.55

36.79

4.4

5.6

0.6

0.7

13.56

1524

11487

(3002030) Lymphocytes/100 leukocytes in Blood

1709

13182

1.54

35.81

4.6

5.7

22.5

26.6

38.09

1568

12034

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1110

7836

1.59

34.01

2.2

2.3

mg/l

3.5

3.0

5.64

935

6586

(3019060) Gas panel - Arterial blood

411

2220

1.96

32.45

6.5

4.7

—

(3018010) Neutrophils/100 leukocytes in Blood

1676

13059

1.51

32.35

4.3

5.6

61.3

58.3

15.52

1550

11997

(3008152) Bicarbonate [Moles/volume] in Arterial blood

399

2150

1.96

31.69

8.6

6.8

mmol/l

24.8

24.5

1.35

377

1994

(40768441) Liver Pathology biopsy report

5.86

30.51

1.1

1.4

—

(3001604) Monocytes [#/volume] in Blood

1735

13867

1.47

28.09

4.3

5.3

e9/l

0.6

1.00

1470

11784

(3048689) Calprotectin [Mass/mass] in Stool

480

2846

1.79

28.07

1.4

2.2

ug/g

264.0

162.5

3.84

378

2213

(3051651) Icteric interference index of Serum or Plasma

137

4.73

28.00

5.0

4.1

—

(3006315) Basophils [#/volume] in Blood

1745

13974

1.46

27.90

4.3

5.3

e9/l

0.0

13.50

1485

11897

(3019198) Lymphocytes [#/volume] in Blood

1764

14211

1.45

27.01

4.4

5.4

e9/l

1.6

1.8

2.48

1525

12275

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

277

1406

2.05

25.93

7.0

4.7

1.6

0.04

255

1320

(3003458) Phosphate [Moles/volume] in Serum or Plasma

594

3818

1.66

25.77

4.5

5.5

mmol/l

1.0

0.12

555

3494

(3007930) Methemoglobin/Hemoglobin.total in Blood

272

1382

2.04

25.38

7.1

4.7

0.9

1.75

251

1298

(3013115) Eosinophils [#/volume] in Blood

1775

14441

1.43

25.08

4.4

5.5

e9/l

0.2

9.52

1543

12453

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

110

381

2.94

23.88

1.2

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1429

11290

1.43

23.15

2.7

2.8

ug/l

170.0

145.6

0.93

1302

10257

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

145

592

2.51

22.89

1.4

1.3

—

(40768800) Prostate Pathology biopsy report

259

3.29

22.23

1.2

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

689

4840

1.52

19.99

2.1

1.9

30.2

30.1

0.21

673

4684

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2988

27214

1.47

19.78

30.5

13.1

ml/min/173m2

77.5

74.7

11.92

2714

21988

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

176

841

2.15

19.32

2.0

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

472

3111

1.59

18.08

3.1

2.8

u/l

265.8

238.9

1.48

451

2876

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

323

1933

1.73

18.01

1.8

1.6

—

(3021589) Normoblasts [#/volume] in Blood

1495

12331

1.35

17.09

16.3

8.8

e9/l

0.0

0.11

1235

9990

(3007853) Bacteria identified in Skin by Aerobe culture

498

3369

1.55

16.98

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

315

2.77

16.94

1.4

1.3

—

(3012501) Base excess in Blood by calculation

141

651

2.21

16.89

4.4

mmol/l

2.6

0.00

101

425

(3024522) Salmonella sp identified in Specimen by Organism specific culture

324

2.72

16.61

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

314

2.75

16.48

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2676

29040

0.73

16.31

4.2

4.9

mmol/l

4.5

1.05

2404

26585

(3005988) Vibrio sp identified in Specimen by Organism specific culture

317

2.72

16.19

1.4

1.3

—

(3010421) pH of Blood

157

770

2.08

16.14

4.2

4.3

7.4

0.69

140

638

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2006

17372

1.33

16.12

3.5

3.0

u/l

66.7

50.6

7.21

1881

15751

(3051611) Lipemic interference index of Serum or Plasma

290

2.80

16.09

4.8

3.7

—

(3044889) 12 lead EKG panel

2390

21239

1.34

16.05

4.5

4.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

330

2.67

16.04

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2650

28781

0.73

16.02

4.2

4.8

mmol/l

1.4

1.03

2366

26168

(3019550) Sodium [Moles/volume] in Serum or Plasma

3276

30704

1.51

15.90

35.5

17.3

mmol/l

139.2

139.8

31.54

3224

29831

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

321

2.69

15.81

1.4

1.3

—

(40761511) CBC panel - Blood by Automated count

3184

29684

1.47

15.74

29.8

13.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3280

30780

1.51

15.49

35.5

17.4

mmol/l

4.0

19.09

3228

29857

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

155

3.45

15.33

1.2

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

513

3567

1.51

15.31

1.6

1.7

—

(40761536) Microorganisms panel - Urine sediment

349

2226

1.63

15.23

4.6

3.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

297

1823

1.68

15.06

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

225

1281

1.80

14.88

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

509

3574

1.49

14.44

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2769

29757

0.74

14.38

4.7

5.5

mmol/l

2.6

0.32

2466

27142

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

299

4621

0.62

14.25

1.2

1.3

iu/ml

72.3

39.9

1.29

1388

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

281

4399

0.61

14.13

1.2

u/ml

12.8

14.8

0.18

1600

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2590

28037

0.75

13.48

6.0

6.6

mmol/mol

41.2

41.0

0.48

2315

25684

(3021447) Carbon dioxide [Partial pressure] in Venous blood

448

3111

1.50

13.37

3.1

3.5

kpa

5.7

5.8

1.76

435

3010

(3002032) Base excess in Venous blood by calculation

446

3099

1.50

13.27

3.1

3.5

mmol/l

2.0

1.9

0.09

351

2502

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

379

2.38

12.96

5.1

6.5

mg/l

12.0

12.1

0.03

342

(3019225) pH of Specimen

444

3100

1.49

12.89

4.3

3.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

152

800

1.94

12.88

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

205

1187

1.77

12.83

2.0

1.6

—

(3013512) EKG study

1162

9531

1.32

12.82

4.2

4.3

—

(3049717) Cytology report of Urine Cyto stain

190

1076

1.81

12.81

2.8

1.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

363

2.40

12.78

2.6

3.0

3.4

1.5

2.18

268

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

241

1464

1.69

12.71

2.5

3.9

mmol/l

24.1

0.00

225

1292

(42529406) Shigella sp [Presence] in Stool by Culture

152

805

1.92

12.65

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

210

1230

1.75

12.63

4.9

4.0

mmol/l

1.2

1.5

2.73

205

1205

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

131

3.39

12.44

3.0

1.7

nmol/l

9.3

4.3

0.46

125

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

796

1.92

12.42

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

125

624

2.04

12.32

2.4

2.2

218.2

197.2

1.71

120

594

(3023183) Ammonium ion [Moles/volume] in Plasma

125

626

2.03

12.22

2.3

2.5

umol/l

34.8

35.5

0.09

105

530

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

355

2392

1.53

12.19

4.8

3.0

mmol/l

1.2

1.94

317

2033

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2583

27838

0.77

11.86

3.8

4.3

mmol/l

1.3

0.05

2283

25081

(3027945) Reticulocytes/100 erythrocytes in Blood

513

3750

1.43

11.66

2.2

2.1

1.8

0.22

458

3258

(3052851) Hemolysis interference index of Serum or Plasma

156

857

1.86

11.63

4.9

3.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

332

2.38

11.41

1.1

g/l

1.6

1.5

1.15

286

(1616796) Gas panel - Central venous blood

129

676

1.94

11.12

3.6

3.7

—

(3020891) Body temperature

222

1373

1.66

10.95

5.4

4.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3246

30787

1.39

10.81

19.2

9.4

u/l

24.1

25.7

6.79

3178

29353

(4281824)

133

3.18

10.80

1.2

—

(40768793) Breast Pathology biopsy report

140

3.09

10.57

1.4

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

124

3.17

9.99

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

124

3.17

9.99

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

167

2.84

9.94

1.2

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2696

25041

1.27

9.53

31.3

15.6

37.5

39.4

18.20

1737

15897

(3002385) Erythrocyte distribution width [Ratio]

2499

23015

1.25

9.45

39.1

16.8

14.6

13.7

82.98

2466

22368

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

172

2.75

9.43

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

4.12

9.42

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

256

1712

1.53

9.11

2.4

2.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

660

8147

0.77

8.34

1.6

1.7

mmol/l

1.5

1.3

1.48

534

6732

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

475

1.94

8.04

3.8

3.5

59.5

58.6

0.24

475

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

337

2442

1.42

7.98

4.6

2.4

ml/min/173m2

61.5

62.1

0.12

138

946

(3013707) Erythrocyte sedimentation rate by Westergren method

2364

21817

1.22

7.95

3.4

4.1

mm/h

16.7

12.7

20.02

2152

19976

(3004716) Salmonella sp identified in Stool by Organism specific culture

170

1071

1.61

7.87

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

425

1.97

7.76

1.3

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

383

2851

1.38

7.75

2.3

2.2

e9/l

69.0

68.2

0.14

292

2191

(3017181) Myelocytes/100 leukocytes in Blood

315

2271

1.42

7.68

3.1

3.7

1.2

0.8

1.83

128

503

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

107

600

1.81

7.59

1.3

1.4

—

(3036489) Thrombin time

150

925

1.65

7.57

2.1

1.8

21.0

21.2

0.32

142

815

(3024731) MCV [Entitic volume]

3307

31773

1.33

7.53

45.3

20.6

91.4

91.6

1.77

3267

31121

(3003434) Protein [Mass/volume] in Pleural fluid

375

2.02

7.51

1.4

1.5

g/l

30.4

28.3

0.70

325

(3035941) MCH [Entitic mass]

3307

31775

1.33

7.51

45.2

20.6

30.2

30.5

18.32

3266

31125

(3037522) Nuclear Ab [Titer] in Serum

256

3598

0.69

7.49

1.2

1.3

titre

597.4

542.0

0.13

773

(3026361) Erythrocytes [#/volume] in Blood

3307

31777

1.33

7.49

45.4

20.7

e12/l

4.3

4.5

123.88

3240

30579

(3010813) Leukocytes [#/volume] in Blood

3307

31781

1.33

7.45

45.4

20.7

e9/l

6.7

6.8

0.97

3240

30582

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.67

7.45

1.3

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3307

31782

1.33

7.44

45.7

20.8

g/l

127.2

136.3

188.03

3264

31135

(3007461) Platelets [#/volume] in Blood

3305

31770

1.33

7.34

45.4

20.7

e9/l

248.4

239.9

9.09

3242

30706

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1976

21492

0.83

7.27

3.2

3.7

pmol/l

15.0

0.25

1728

19158

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

4.30

7.20

1.2

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

302

2190

1.41

7.13

3.1

3.8

0.2

0.1

1.34

118

471

(3024354) Oxygen [Partial pressure] in Venous blood

349

2598

1.38

7.06

2.9

3.0

kpa

4.5

0.19

336

2504

(40767503) Oxygen content in Capillary blood by calculation

112

656

1.73

6.88

2.8

2.5

15.2

16.2

1.27

361

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

276

1990

1.42

6.74

3.1

3.5

mmol/l

1.9

1.8

0.15

200

1440

(3028308) Erythrocytes [#/volume] in Pleural fluid

296

2.08

6.66

1.4

1.5

e6/l

22143.4

77223.8

1.11

170

(3029937) Albumin [Presence] in Urine by Test strip

927

7899

1.23

6.63

4.4

4.1

estimate

0.0

0.35

322

2361

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

2.87

6.62

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

2.87

6.62

1.4

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

105

2.87

6.62

1.4

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1586

14246

1.20

6.54

5.6

5.0

estimate

0.0

0.50

370

2452

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

652

5357

1.26

6.47

1.2

u/ml

1.6

2.1

0.56

163

1387

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2760

28980

0.82

6.44

4.5

5.1

mmol/l

6.2

6.1

1.19

2447

26059

(3012441) Differential panel - Pleural fluid

280

2.09

6.43

1.4

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

383

1.92

6.43

1.9

1.8

88.6

89.7

0.70

377

(3026493) Urate [Moles/volume] in Serum or Plasma

700

8353

0.80

6.41

2.5

2.6

umol/l

2364.4

5869.1

2.19

594

7051

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

166

2.42

6.34

1.8

1.9

u/field

3.7

1.9

0.79

116

(3023199) Leukocytes [#/volume] in Pleural fluid

330

1.99

6.30

1.4

1.5

e6/l

832.0

2119.4

1.23

237

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

284

2084

1.39

6.28

3.1

3.6

kpa

5.1

5.2

0.53

262

1904

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.17

6.28

1.5

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

159

1044

1.55

6.24

5.3

4.4

mmol/l

3.8

3.9

4.01

150

979

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

577

1.73

6.23

1.3

1.4

—

(3009343) pH of Capillary blood

280

2053

1.39

6.22

3.1

3.6

7.4

0.16

250

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

170

1134

1.52

6.20

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

291

2149

1.38

6.20

1.3

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

245

2.14

6.15

1.3

u/l

306.6

279.0

0.17

230

(3022217) INR in Platelet poor plasma by Coagulation assay

602

4936

1.26

6.05

20.9

29.9

inr

1.3

1.5

2.11

645

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

2.77

6.04

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

108

651

1.68

6.03

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

108

651

1.68

6.03

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.16

6.00

2.4

1.3

—

(3033799) Differential panel - Peritoneal fluid

3.16

6.00

2.6

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

117

2.66

5.98

2.0

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

1578

14254

1.18

5.90

4.2

3.7

estimate

0.0

0.50

361

2412

(3002179) Metamyelocytes/100 leukocytes in Blood

281

2082

1.38

5.88

2.9

3.6

0.7

0.6

0.39

374

(3009261) Glucose [Presence] in Urine by Test strip

1595

14425

1.18

5.87

4.3

3.7

estimate

0.0

1.08

364

2345

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1424

12758

1.19

5.85

3.7

4.0

ng/l

34.7

83.6

2.48

1140

9583

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

295

1.98

5.63

1.3

1.4

pmol/l

255.4

81.1

0.78

284

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.00

5.52

1.5

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.00

5.52

1.5

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

758

6444

1.22

5.43

3.4

4.1

ng/l

539.8

483.1

0.11

632

5461

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

212

1522

1.42

5.36

1.6

1.5

g/l

1.7

1.5

1.50

182

1305

(40768806) Pleura Pathology biopsy report

260

2.01

5.31

1.4

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.21

1.0

0.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.01

5.09

1.9

2.7

e6/l

21072.0

32812.6

0.14

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.85

5.07

1.3

1.4

1.2

2.6

1.02

(3000570) Elastase.pancreatic [Mass/mass] in Stool

123

801

1.55

5.07

1.3

1.4

ug/g

247.3

284.8

1.35

493

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.09

5.06

1.3

2.1

g/l

11.7

15.0

1.15

(3025159) Blasts/100 leukocytes in Blood

274

2079

1.34

4.96

3.1

3.9

0.6

0.3

0.23

414

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.78

4.87

1.8

3.0

e6/l

725.9

644.4

0.08

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

11.45

4.78

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

243

1.99

4.78

2.4

2.7

59.2

59.7

0.05

153

(3028626) Oxygen [Partial pressure] in Capillary blood

109

703

1.57

4.71

3.0

2.8

kpa

7.9

7.8

0.21

104

653

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.72

4.67

3.7

2.8

—

(4010399)

162

2262

0.70

4.61

1.3

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

910

10308

0.85

4.60

2.1

2.2

u/l

210.6

221.4

0.15

851

9597

(3017143) Hepatitis C virus Ab [Presence] in Serum

268

2051

1.33

4.59

1.3

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

220

2.01

4.55

1.3

1.4

—

(4094501)

868

0.54

4.48

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

380

1.75

4.44

2.0

5.3

iu/ml

268.7

434.1

—

(3044007) Cell count panel - Peritoneal fluid

2.93

4.43

2.2

2.5

—

(3045788) Cell count panel - Pleural fluid

251

1.92

4.38

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

113

0.00

4.35

0.0

16.4

—

1365.7

—

108

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1258

0.62

4.33

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

211

2.00

4.30

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

211

2.00

4.30

1.4

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

211

2.00

4.30

1.4

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

545

4585

1.22

4.28

1.4

1.3

g/l

2.7

0.06

303

2603

(3021901) Oxygen saturation in Capillary blood

609

1.57

4.25

3.0

2.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

107

0.00

4.20

0.0

11.7

—

786.3

—

100

(3045142) Bone marrow Pathology biopsy report

227

1.95

4.19

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

654

5618

1.20

4.13

4.1

4.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

826

7242

1.18

4.13

4.6

3.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

279

1.84

4.09

1.3

1.5

—

(1002224) Polysomnography panel

881

0.56

4.09

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

402

3295

1.25

4.04

1.5

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

129

1824

0.70

3.98

2.2

2.4

au/ml

64.4

27.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.64

3.92

2.6

1.1

ug/l

0.8

2.9

—

(3022313) Gas panel - Capillary blood

198

1486

1.35

3.91

3.0

3.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

262

1.84

3.89

3.2

—

(3008898) HLA-B27 [Presence]

673

0.52

3.85

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.54

3.76

1.7

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

280

1.80

3.75

2.7

3.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

662

1.51

3.71

1.8

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

779

0.56

3.69

1.3

1.7

mg/l

2.9

3.9

0.34

549

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

904

0.59

3.68

1.1

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

182

1.99

3.67

1.3

u/l

9.8

10.4

0.17

161

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

122

2.22

3.66

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

122

2.22

3.66

1.4

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

110

2.28

3.61

1.8

2.6

—

(1761868) Lipid panel - Serum or Plasma

789

8887

0.86

3.58

3.0

3.3

—

(3020393) Adenovirus Ag [Presence] in Stool

5.30

3.50

1.1

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

171

1278

1.35

3.50

3.0

4.0

mmol/l

24.8

24.7

0.07

152

1162

(3003327) Ova and parasites identified in Stool by Light microscopy

109

754

1.46

3.48

1.6

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1013

0.63

3.48

1.2

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

153

2.03

3.39

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

570

1.52

3.39

1.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

154

2.02

3.34

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

441

0.45

3.32

4.0

4.3

umol/l

340.9

348.6

0.08

373

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2556

26579

0.88

3.30

3.9

4.5

mu/l

2.1

0.00

2240

23842

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

203

1572

1.31

3.28

2.4

2.5

0.7

0.11

194

1502

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

369

1.64

3.27

1.3

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

620

1.48

3.17

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

248

0.36

3.16

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

104

2.22

3.15

1.2

1.4

46.6

63.7

0.99

(3020682) Albumin/Creatinine [Ratio] in Urine

1029

11282

0.88

3.12

4.2

4.0

mg/mmol

11.0

8.4

1.11

669

7202

(3035880) pH of Pleural fluid

145

2.01

3.09

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

1.89

3.04

1.4

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1062

0.66

3.02

1.5

—

(4034850)

1109

0.67

3.01

12.6

10.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

231

2873

0.79

3.01

1.5

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1157

10605

1.13

3.01

2.6

3.2

ng/l

1528.2

1611.8

0.31

1021

9167

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

418

1.56

2.98

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

363

1.61

2.97

1.2

1.3

—

(3012516) Albumin [Mass/volume] in Urine

973

10664

0.88

2.89

3.4

3.2

mg/l

307.9

230.0

0.27

663

6863

(3015235) Bicarbonate [Moles/volume] in Capillary blood

117

855

1.38

2.82

3.2

3.1

mmol/l

24.1

25.0

0.97

104

755

(40765096) Chromosome analysis panel by Banding

2.86

2.74

1.2

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

218

1747

1.26

2.74

3.6

3.1

mmol/l

24.4

25.2

1.88

207

1682

(3005322) IgE [Units/volume] in Serum or Plasma

112

1513

0.73

2.72

1.2

1.3

u/ml

229.0

237.5

0.04

1391

(3009508) Creatinine [Moles/volume] in Urine

993

10828

0.89

2.69

3.3

3.2

mmol/l

7.4

7.5

0.32

795

9009

(3004119) Hemoglobin [Mass/volume] in Venous blood

260

2136

1.23

2.64

2.9

3.1

g/l

123.8

130.6

5.45

253

2073

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.67

2.59

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

795

0.65

2.51

1.4

1.6

iu/ml

1.2

3.8

0.35

182

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1019

0.69

2.50

1.2

u/ml

7.4

0.8

—

105

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

311

1.58

2.43

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

175

0.34

2.40

1.8

1.1

—

(3014891) Appearance of Pleural fluid

2.75

2.37

2.3

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

841

0.67

2.34

1.2

1.4

—

(21494755) Public health laboratory ask at order entry panel

106

1407

0.75

2.33

1.2

1.4

—

(3024928) Oxygen saturation in Venous blood

678

1.38

2.33

1.4

3.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

237

1.65

2.31

1.9

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

101

748

1.36

2.30

2.7

2.2

g/l

122.4

130.2

2.17

558

(3021879) Hepatitis B virus core Ab [Presence] in Serum

158

1247

1.28

2.30

1.2

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

329

0.48

2.29

1.3

1.7

—

(3019977) pH of Arterial blood

185

1.74

2.27

1.8

2.1

7.4

0.29

(3045414) Leukocytes [Presence] in Urine

168

1339

1.27

2.26

2.4

1.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

384

1.49

2.20

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

602

0.63

2.20

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

467

1.44

2.18

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

273

1.58

2.16

1.8

2.1

u/field

2.7

1.8

0.43

104

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

211

1.66

2.16

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

954

0.71

2.15

1.2

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

198

1.67

2.08

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

609

1.37

2.04

1.0

1.1

u/ml

1.3

7.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

673

6103

1.12

2.03

1.6

1.7

mg/l

2.2

1.3

3.37

547

4723

(44816559) Phosphatidylethanol [Mass/volume] in Blood

475

0.61

1.96

1.2

1.3

—

(3042631) Mycobacterium sp identified in Specimen

395

1.45

1.95

1.8

3.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

257

1.56

1.94

1.9

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.75

1.93

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

172

1.69

1.92

2.3

2.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.57

1.92

1.0

1.2

ng/l

82.6

153.5

—

(3000012) Reticulocyte production index

173

1.68

1.89

1.3

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.18

1.88

1.9

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

601

0.66

1.86

1.1

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

299

2581

1.17

1.86

1.3

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

363

3182

1.16

1.85

2.5

3.1

ng/l

243.6

228.9

0.25

326

2927

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

611

0.67

1.84

1.0

1.3

e6/l

4.3

27.2

1.31

476

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

610

0.67

1.82

1.2

1.4

e6/l

221.3

884.8

1.52

502

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

133

1649

0.80

1.79

1.8

1.9

—

(3002619) Bacteria identified in Specimen by Culture

2.34

1.77

1.5

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

941

0.74

1.75

2.6

2.2

ug/min

214.6

110.6

0.54

545

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1172

11019

1.09

1.74

4.7

4.0

—

(3045424) Erythrocytes [Presence] in Urine

482

1.38

1.72

1.8

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

155

1.68

1.72

1.5

u/l

13.9

5.9

0.76

(3014271) Vancomycin [Susceptibility]

202

1.59

1.70

2.8

3.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

843

0.73

1.68

1.5

e6/l

8362.5

13796.8

0.88

613

(3006922) Hepatitis E virus Ab [Presence] in Serum

141

1.71

1.67

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

146

0.41

1.64

1.2

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

265

0.53

1.64

1.1

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

630

0.69

1.63

1.4

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

212

0.47

1.63

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

262

3018

0.86

1.63

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

287

1.47

1.59

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.28

1.53

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

249

1.49

1.52

1.1

1.2

u/l

103.1

56.4

0.44

157

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.59

1.51

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

143

0.42

1.51

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

672

0.73

1.45

1.2

u/ml

2.1

5.0

—

111

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

426

0.65

1.45

1.3

1.4

54.9

63.3

0.41

279

(1001926) Buprenorphine [Presence] in Urine by Screen method

240

0.54

1.43

1.3

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

133

1.66

1.42

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

133

1.66

1.42

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

314

0.60

1.41

1.2

1.4

47.3

27.4

—

206

(3003888) Timothy IgE Ab [Units/volume] in Serum

251

0.56

1.40

1.0

u/ml

2.6

3.6

—

115

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

181

1.55

1.39

1.2

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

712

0.74

1.38

1.2

—

52.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

150

1.60

1.37

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

120

0.42

1.37

1.0

1.2

—

(3017569) Oxygen content in Arterial blood

198

1.52

1.37

2.0

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

190

1.53

1.37

2.0

2.1

ug/min

64.8

220.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.94

1.36

6.6

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.83

1.35

1.3

1.5

—

(3011288) Drugs identified in Urine by Screen method

196

0.51

1.34

1.0

2.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.04

1.32

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

246

0.57

1.32

1.0

u/ml

1.8

0.9

—

(3014051) Protein [Presence] in Urine by Test strip

713

1.25

1.27

2.7

2.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.94

1.27

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

194

1.50

1.26

2.7

2.5

—

(36660697) Celiac disease serology panel - Serum

227

1986

1.15

1.26

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

290

0.62

1.23

1.2

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

189

0.53

1.22

2.1

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

525

0.72

1.22

1.4

—

(3021788) Differential panel - Synovial fluid

605

0.74

1.21

1.2

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

757

7094

1.08

1.20

3.4

3.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.83

1.19

1.3

1.5

17.9

27.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

109

1.65

1.18

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.88

1.17

1.1

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

248

1.41

1.16

1.0

u/ml

4.1

2.7

0.31

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

2.00

1.16

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

2.00

1.16

1.2

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

1.16

0.0

1.2

—

10.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.81

1.14

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

386

1.33

1.14

7.0

25.7

mmol/l

6.7

7.7

2.26

315

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

150

1.54

1.14

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

103

1.65

1.12

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.96

1.11

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.96

1.11

1.2

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

561

0.75

1.11

1.1

1.3

—

(3027008) Opiates [Presence] in Urine

305

0.65

1.10

1.2

1.6

—

(3017732) Neutrophils [#/volume] in Blood

213

1878

1.14

1.09

4.1

3.2

e9/l

4.1

0.04

161

1319

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

137

0.51

1.09

1.4

1.3

—

(4146454)

407

1.31

1.09

3.4

2.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

160

1.50

1.09

2.3

1.4

u/l

216.1

2430.9

0.76

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

292

0.65

1.09

1.0

1.1

u/ml

1.6

1.5

—

112

(3025130) Human papilloma virus identified in Specimen

144

1.53

1.08

1.5

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1164

0.83

1.06

1.7

u/l

37.8

38.1

0.05

969

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

290

0.65

1.06

1.1

—

0.3

—

(3024263) Appearance of Synovial fluid

192

0.57

1.05

1.3

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

122

0.49

1.05

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

878

0.80

1.04

3.2

1.5

g/l

0.0

0.00

805

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

965

0.81

1.03

3.4

1.4

g/l

0.0

1.08

879

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

855

0.80

1.03

1.4

1.7

—

(3005033) Fetal Nuchal fold Thickness US

1.96

1.03

1.2

1.4

—

(3020650) Glucose [Presence] in Urine

1.84

1.02

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.92

1.02

1.2

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

196

1.43

1.01

2.1

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.88

1.00

1.3

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

333

0.69

1.00

1.3

1.2

e6/l

91264.0

249013.5

0.89

233

(3036603) Volume of Urine

164

1.47

0.99

2.0

1.3

1781.0

1968.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

414

1.28

0.98

1.8

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.17

0.98

1.0

—

5.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.17

0.98

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.97

0.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

74.9

—

(3028300) Cannabinoids [Presence] in Urine

307

0.68

0.97

1.2

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

401

4341

0.91

0.96

11.8

7.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

354

1.30

0.96

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

714

0.79

0.96

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1476

14252

1.06

0.96

4.6

4.0

ug/l

2.7

2.4

0.46

1272

12736

(3010838) Calcium [Moles/time] in 24 hour Urine

143

0.56

0.93

1.4

1.8

—

12.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

755

0.80

0.93

1.6

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

304

0.69

0.93

1.2

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

0.92

1.0

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

192

1.41

0.92

3.6

3.3

13.1

13.3

0.54

192

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.82

0.92

1.3

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

895

0.82

0.91

3.1

1.5

g/l

0.0

0.00

810

(3016018) Differential panel - Cerebral spinal fluid

279

0.68

0.91

1.1

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.63

0.90

1.1

1.3

—

(3023419) Bacteria identified in Sputum by Culture

428

0.75

0.89

2.3

2.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.07

0.89

1.0

1.3

—

(4015189)

102

0.49

0.89

1.4

2.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

592

1.22

0.89

1.2

1.5

—

(3027944) Amphetamines [Presence] in Urine

300

0.70

0.87

1.2

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

275

0.69

0.85

1.1

—

27.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.94

0.84

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

111

0.54

0.83

2.8

2.6

umol/l

29.2

30.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

545

0.79

0.82

1.8

iu/l

6.4

4.5

0.26

169

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.74

0.82

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.74

0.82

2.5

2.7

u/field

0.5

0.4

—

(3011648) Oxygen content in Venous blood

240

1.34

0.82

1.1

1.9

11.0

0.02

240

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

355

1.27

0.81

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.61

0.81

2.5

2.3

mmol/l

8.7

8.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.6

—

0.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

233

1.33

0.79

1.3

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.79

0.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

1308

0.87

0.78

2.7

1.4

g/l

3.7

3.8

0.41

915

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

1222

0.86

0.78

2.6

1.4

g/l

10.3

0.00

1009

(3004775) Volume in Urine collected for unspecified duration

304

0.72

0.78

1.8

2.3

667.0

628.6

0.26

192

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.51

0.77

1.0

1.2

u/ml

—

11.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

584

0.80

0.77

1.1

1.2

—

10.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

123

0.57

0.77

1.0

1.2

—

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.77

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

100

0.50

0.77

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

200

1805

1.11

0.77

2.4

2.2

g/l

9.8

10.8

2.95

183

1644

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

200

1.35

0.76

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

770

1.17

0.75

2.6

1.5

—

(3019150) Specific gravity of Urine by Refractometry

633

6663

0.94

0.75

4.1

4.2

kg/l

1.0

0.05

990

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

1312

0.87

0.74

2.7

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

1312

0.87

0.74

2.7

1.4

g/l

7.4

7.5

0.18

952

(3023323) Follitropin [Units/volume] in Serum or Plasma

387

1.24

0.74

1.2

1.3

iu/l

44.8

32.0

1.46

339

(3022621) pH of Urine by Test strip

222

2020

1.10

0.74

3.3

3.1

—

(3000492) Spirometry study

223

2445

0.91

0.74

1.4

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

381

4079

0.93

0.73

4.3

5.0

32.9

0.02

249

2689

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

136

0.59

0.72

1.1

—

(40768797) Stomach Pathology biopsy report

426

3993

1.08

0.72

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

826

7909

1.06

0.72

1.7

1.6

nmol/l

19.9

20.2

0.24

707

6657

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

151

1.39

0.71

2.4

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

499

1.21

0.70

3.2

3.1

—

(3003181) Sodium [Moles/volume] in Urine

554

1.19

0.70

1.5

1.3

mmol/l

71.5

63.6

0.59

443

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1029

0.86

0.70

2.8

1.4

g/l

37.7

37.6

0.03

852

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

217

0.69

0.70

1.1

1.2

mmol/l

2.7

2.1

0.72

203

(3016650) Hepatitis A virus Ab [Presence] in Serum

327

1.26

0.70

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1092

0.87

0.69

3.0

1.5

g/l

0.6

0.5

0.15

925

(3034274) Bile acid [Moles/volume] in Serum --fasting

102

1.47

0.67

2.1

1.2

umol/l

39.2

8.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

121

0.58

0.67

1.1

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

267

1.28

0.66

2.1

1.7

—

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

285

1.27

0.66

1.1

u/ml

—

(4212803)

1.79

0.66

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.61

0.65

1.5

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

259

0.73

0.65

1.2

1.3

—

23.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.47

0.64

1.6

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

234

0.73

0.62

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

397

1.21

0.61

1.5

2.1

mg/l

48.7

26.2

0.55

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

379

0.79

0.61

1.1

1.2

miu/ml

322.3

201.9

—

143

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.59

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.59

0.0

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

254

2733

0.92

0.59

1.5

1.7

1.6

0.10

217

2309

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

114

1016

1.13

0.59

2.1

2.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

441

0.81

0.57

1.4

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.56

1.0

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

383

1.20

0.56

1.1

—

(3023410) Appearance of Cerebral spinal fluid

252

0.75

0.56

1.2

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

347

1.21

0.56

1.2

1.4

u/ml

78.5

111.3

—

(3044941) Cell count panel - Synovial fluid

537

0.84

0.55

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

496

1.17

0.54

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

116

1042

1.12

0.54

2.7

1.6

mg/l

35.7

42.7

0.53

843

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

122

1350

0.90

0.53

1.2

iu/ml

183.1

129.2

0.66

491

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

110

1224

0.90

0.53

2.8

1.4

g/l

3.1

3.0

0.13

935

(3024869) Neuronal Ab [Presence] in Serum

1.45

0.53

1.0

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

108

1.39

0.53

1.9

2.2

91.2

95.6

0.20

100

(3003740) Influenza virus B Ag [Presence] in Specimen

241

1.25

0.52

1.0

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

116

1045

1.11

0.52

2.7

1.6

mg/l

53.0

50.6

0.15

850

(3003129) Base excess in Capillary blood by calculation

0.61

0.52

1.0

1.5

mmol/l

-0.7

0.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.46

0.50

1.0

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

688

1.14

0.50

2.5

2.7

mg/l

1.9

1.7

0.67

605

(4133840)

1.49

0.49

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

562

0.85

0.49

1.1

1.2

u/l

51.2

29.6

0.49

487

(3002523) Influenza virus A Ag [Presence] in Specimen

243

1.24

0.49

1.0

1.1

—

(21494434) Karyotype in Bone marrow

243

1.24

0.49

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.56

0.49

1.4

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.56

0.49

1.3

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.56

0.49

1.3

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

400

1.18

0.48

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

398

0.83

0.47

1.0

—

(3004451) EKG impression Narrative

173

1.27

0.46

1.2

1.3

—

(44806118)

282

1.21

0.46

1.3

1.4

—

(44790047)

282

1.21

0.46

1.3

1.4

—

(44790048)

282

1.21

0.46

1.3

1.4

—

(44790049)

282

1.21

0.46

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

0.68

0.45

1.0

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

298

0.80

0.45

1.0

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

245

2302

1.07

0.44

1.8

nmol/l

406.0

367.5

2.20

228

2072

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

139

1.30

0.43

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

111

1011

1.10

0.43

2.8

1.5

ratio

1.4

2.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

461

1.15

0.43

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.43

0.42

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

203

1.23

0.42

5.9

10.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1123

11487

0.97

0.41

4.1

3.9

20.4

24.2

14.55

553

5737

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.8

—

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.41

0.0

1.3

—

0.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

172

0.75

0.40

1.4

1.9

nmol/l

16.8

15.5

0.23

153

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.47

0.40

2.4

2.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.47

0.40

2.4

2.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

194

0.77

0.40

1.1

1.3

u/ml

0.1

1.3

—

(3025577) Chromium [Mass/volume] in Blood

260

0.81

0.40

1.9

2.0

ug/l

2.2

1.9

0.28

218

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.40

0.0

1.5

—

(3022689) Creatine [Moles/volume] in Urine

103

0.68

0.39

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.41

0.39

1.1

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.39

0.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.39

0.0

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

106

0.66

0.39

1.1

1.2

40.7

57.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

353

1.16

0.39

1.3

1.2

u/ml

3.4

5.8

1.21

163

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

124

1.29

0.38

1.1

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

179

1908

0.93

0.37

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

123

1329

0.92

0.37

3.1

2.9

pmol/l

4.3

4.4

0.79

116

1145

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

158

0.76

0.37

1.1

—

(3048879) Bone marrow aspiration report

1.39

0.36

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

100

917

1.09

0.36

5.1

4.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.62

0.35

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

108

1.30

0.35

1.1

2.1

18.9

15.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

298

0.84

0.34

2.0

1.7

u/ml

32.2

25.2

—

(44813793)

156

0.77

0.34

1.1

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.37

0.34

1.2

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.33

0.33

1.0

2.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.32

0.33

1.2

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

210

0.81

0.33

1.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1406

13826

1.03

0.33

2.1

pmol/l

86.5

93.2

6.39

820

7238

(3045716) Anion gap in Serum or Plasma

182

1.21

0.33

2.4

2.0

mmol/l

8.9

9.6

0.53

142

(3051387) C reactive protein [Mass/volume] in Capillary blood

697

0.90

0.32

3.7

mg/l

36.0

27.9

0.64

455

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

781

7999

0.97

0.32

3.0

2.8

ug/l

0.7

0.05

545

5605

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

154

0.78

0.32

2.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

101

1.29

0.31

1.2

2.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

110

1.27

0.31

1.1

—

(3008295) Osmolality of Serum or Plasma

276

1.16

0.31

1.3

1.4

mosm/kgh2o

274.5

277.9

0.42

205

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

202

1.19

0.31

1.5

1.2

mmol/l

11.7

12.2

—

(4211845)

156

1.22

0.30

4.4

3.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.71

0.30

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

304

0.85

0.30

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.30

0.30

1.3

1.8

25.9

26.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.30

0.30

1.3

1.9

18.4

8.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

630

0.90

0.30

1.3

1.5

nmol/l

1.0

0.8

0.98

508

(21494814) CD8 cells/100 lymphocytes in Specimen

1.27

0.30

1.0

2.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

201

1910

1.05

0.29

2.0

2.2

nmol/l

10.4

14.6

8.26

169

1655

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

185

0.81

0.29

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

185

0.81

0.29

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

185

0.81

0.29

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

185

0.81

0.29

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

451

0.89

0.29

1.1

iu/ml

193.3

457.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

439

0.89

0.28

1.4

1.3

u/l

22.1

9.0

2.89

356

(1175426) CD3 cells/100 lymphocytes in Blood

112

1.25

0.28

1.1

2.1

66.0

72.1

1.05

103

(4027681)

129

0.77

0.28

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

221

2312

0.95

0.28

2.5

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

441

1.11

0.27

4.1

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

150

0.80

0.27

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

182

0.82

0.26

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

182

0.82

0.26

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

182

0.82

0.26

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.68

0.26

1.0

1.1

—

(3024471) HLA-A [Type]

0.68

0.26

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.24

1.7

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.24

1.7

2.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

701

6863

1.03

0.24

1.7

1.8

nmol/l

1161.5

1146.8

0.14

536

5130

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.74

0.24

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.72

0.24

1.0

1.1

—

30.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.71

0.24

1.2

1.5

ug/l

10.4

9.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

115

1.22

0.23

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.32

0.23

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

361

1.11

0.22

1.3

1.2

u/ml

5.3

3.6

0.24

109

(4062490)

253

0.87

0.22

1.4

—

(3015183) Erythrocyte sedimentation rate

0.77

0.22

1.4

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

181

1.16

0.22

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.74

0.22

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

333

1.11

0.22

1.2

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

219

1.14

0.22

1.1

1.2

—

5.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.19

0.21

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.20

0.0

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

10.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

1.18

0.20

1.1

—

(3044927) Protein electrophoresis panel - Urine

396

0.91

0.19

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

404

1.09

0.19

1.2

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

122

0.82

0.19

2.2

umol/l

59.1

57.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

270

0.89

0.19

1.0

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

301

0.90

0.18

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

353

0.91

0.18

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

730

7181

1.02

0.18

1.7

pmol/l

14405830.1

30409875.7

0.50

597

5837

(3047189) Immunofixation for 24 hour Urine

128

1.17

0.18

1.7

1.1

—

(4306422)

339

1.09

0.17

1.2

—

(40761535) Cells panel - Urine sediment

285

2774

1.03

0.17

3.0

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

150

1446

1.04

0.16

1.9

1.4

g/l

1.4

1.1

0.60

139

1304

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.78

0.15

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.76

0.15

1.0

1.1

—

(3034426) Prothrombin time (PT)

0.75

0.15

1.2

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

102

1.18

0.15

1.4

1.6

umol/l

72.2

150.1

—

(3037756) Immunofixation for Serum or Plasma

624

1.06

0.15

1.6

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

757

0.95

0.14

1.4

1.5

g/l

0.3

0.2

0.83

718

(21491868) Cryoglobulin [Mass/volume] in Serum

0.82

0.13

1.1

1.2

—

0.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

273

2670

1.02

0.13

2.7

1.6

g/l

64.3

66.7

4.46

244

2365

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

108

0.83

0.13

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

252

0.91

0.12

1.3

1.4

g/l

0.3

0.4

1.72

178

(3027135) IgG subclass 1 [Mass/volume] in Serum

252

0.91

0.12

1.3

1.4

g/l

6.0

6.9

0.69

178

(3028192) IgG subclass 2 [Mass/volume] in Serum

252

0.91

0.12

1.3

1.4

g/l

2.3

3.0

2.16

178

(3006462) Nitrate [Presence] in Urine

142

1.13

0.12

4.7

3.5

—

(3016750) Collection duration of Urine

200

0.90

0.12

1.9

2.0

min

493.1

494.9

0.02

146

(3006270) Folate [Moles/volume] in Blood

303

0.92

0.12

1.3

1.2

nmol/l

362.4

344.4

0.17

241

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

104

1077

0.96

0.12

1.6

titre

193.3

284.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

233

2379

0.98

0.11

3.2

3.8

ng/l

93.6

97.0

0.20

195

1994

(4024509)

332

0.93

0.11

1.7

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1186

11769

1.01

0.11

2.1

2.2

nmol/l

76.3

78.7

1.89

1032

10225

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

329

1.06

0.10

1.2

1.3

nmol/l

—

(3000330) Specific gravity of Urine by Test strip

177

1730

1.02

0.10

6.0

3.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

310

1.06

0.09

2.6

1.2

—

(4268621)

232

1.08

0.09

2.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

114

0.88

0.09

1.0

1.2

—

(3017704) Immunofixation for Urine

184

1.09

0.09

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

319

0.94

0.09

1.1

1.2

mmol/l

7.7

0.00

223

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

134

0.89

0.08

1.0

1.2

—

(40768443) Skin Pathology biopsy report

113

1160

0.97

0.08

1.1

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.83

0.08

1.0

1.1

129.8

99.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.77

0.08

1.2

pmol/l

163.8

242.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.04

0.08

1.1

umol/l

18.6

15.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.86

0.07

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.86

0.07

1.3

1.1

—

(40757373) Influenza virus identified in Isolate

0.86

0.07

1.3

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.08

0.07

1.0

2.1

—

135406.5

—

(3032057) Clostridioides difficile [Presence] in Stool

1.05

0.07

2.4

1.9

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

147

1.09

0.07

1.1

1.3

mmol/l

6.0

6.2

0.45

137

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.83

0.07

5.1

8.1

—

(3028433) Virus identified in Specimen by Culture

1.05

0.07

1.3

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.89

0.06

1.0

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

0.91

0.06

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.84

0.06

2.9

3.0

mu/l

14.4

20.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

346

1.04

0.05

1.2

u/ml

197.4

278.9

1.82

214

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

772

1.02

0.05

1.4

1.5

g/l

1.1

1.2

0.38

730

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

397

1.03

0.04

1.6

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

180

0.94

0.04

1.4

1.3

nmol/l

1.2

0.01

137

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

477

1.03

0.04

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

583

0.98

0.03

1.2

1.3

—

(3003338) MCHC [Mass/volume]

2361

23572

1.00

0.03

40.7

18.6

g/l

330.0

332.4

30.10

2340

23337

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1423

14253

1.00

0.03

2.2

2.3

—

(3038026) Centromere Ab [Units/volume] in Serum

241

1.04

0.02

1.1

1.2

—

65.6

—

(3006653) Thiamine [Moles/volume] in Blood

148

0.95

0.02

1.0

1.2

nmol/l

154.6

141.1

0.24

148

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

142

1.06

0.02

1.0

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

341

1.03

0.02

3.2

3.1

mg/l

43.6

39.6

0.09

262

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

341

1.03

0.02

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

328

0.98

0.02

1.0

1.3

—

(44806420)

133

1.05

0.01

2.4

2.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

341

3397

1.00

0.01

2.0

2.4

ug/l

6.2

7.5

0.77

289

2965

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

377

0.98

0.01

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

383

1.02

0.01

1.3

mu/l

46.1

64.6

0.65

341

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

243

2435

1.00

0.00

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

315

0.98

0.00

2.8

3.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

804

0.99

0.00

3.0

3.1

nmol/l

0.8

0.66

620

(40768446) Kidney Pathology biopsy report

105

0.95

0.00

1.4

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

401

1.00

0.00

1.3

1.7

g/l

1.2

0.9

0.28

305

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

162

0.99

0.00

3.1

4.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

361

1.00

0.00

1.2

1.3

pmol/l

212.6

278.9

1.25

272

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

939

1.00

0.00

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

199

1.00

0.00

1.2

1.5

umol/l

15.6

14.2

0.32

183

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

121.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.93

0.00

1.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1215.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

5.8

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.95

0.00

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

4.2

—

23.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(4198724)

1.00

0.00

1.8

1.6

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.4

—

633.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.90

0.00

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.92

0.00

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.89

0.00

1.7

1.8

ug/l

0.9

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.02

0.00

1.2

1.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.94

0.00

1.2

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.92

0.00

5.4

1.7

234.3

161.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.94

0.00

5.6

8.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

0.94

0.00

1.0

2.0

e9/l

0.1

—

(4038314)

0.00

0.0

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

283.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

3.8

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_ADENO_EXALLC – Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers) (C3_RECTUM_ADENO_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints